Teva

Teva agrees to settlement in price-fixing case in the US

Israel-based drugmaker agrees to pay a $225 million fine to settle price-fixing charges related to three of its medicines.

Opioid addiction saga:

Teva to pay Nevada $193 million

Israel-based drugmaker agrees to pay Nevada to settle claims that its marketing practices fueled opioid addiction.

Teva reaches settlement with Texas over opioid lawsuit

Israeli drugmaker reaches settlement worth $225 million to resolve claims it fueled an opioid epidemic in Texas.

Teva investigated in Europe for hindering access to medicine

Israeli drug-maker investigated by over whether it illegally hindered rivals’ access to its multiple sclerosis medicine.

Teva in talks to produce COVID vaccines

Teva chief says company in talks with COVID-19 vaccine makers to co-produce some shots.

EU fines Teva for colluding to delay a cheap sleep disorder drug

European Commission says Teva was in breach of rules after it effectively agreed with another company to keep a cheaper drug off the market.

US accuses Israeli pharmaceutical giant of fixing drug prices

US Justice Department charges Teva of illegally fixing drug prices between 2013 and 2015.

Teva will receive $50m from former directors for bribery fines

Former Teva executives will pay shareholders $50 million in compensation for fines the co. was forced to pay for bribery charges.

Teva CEO to Netanyahu: We will help dismissed employees

Head of struggling pharmaceutical giant refuses to budge after government demands Jerusalem factories remain open, offers to train employees

Teva employees threaten to blow up factory

'Our factory is a ticking time bomb' say employees of pharmaceutical giant Teva. 'We have access to explosives and poison - so be prepared.'

Israel grinds to a halt in strike over Teva layoffs

Large part of Israeli services to grind to a halt as general strike aims at stopping pharmaceutical giant Teva from firing 1,700 workers.

Histadrut calls strike over Teva cuts

Histadrut to hold nationwide strike on Sunday following reports that troubled drug giant will cut thousands of jobs.

Riots outside Teva's Jerusalem factory over mass layoffs

Employees burn tires, block roads as pharmaceutical giant seeks to cut 14,000 jobs.

PM to CEO of drug giant: Minimize harm to workers

Netanyahu speaks with CEO of Teva Pharmaceutical Industries, amidst company's reported intention to cut thousands of workers in Israel.

Israeli drug giant to cut thousands of jobs

Teva Pharmaceuticals reportedly to unveil program cutting over 4,000 jobs, mainly in Israel and the US.

Pharmaceutical giant to lay off thousands worldwide

Teva lays off thousands of workers, closes six factories, after losing $6 billion.

Teva to lay off 350 employees in Israel

Teva to lay off some of its 7,000 employees in Israel it reorganizes.

Teva expected to name new CEO

Teva Pharmaceutical expected to name Pascal Soriot as its next CEO, reports say.

Teva CEO steps down

Erez Vigodman, CEO of Israeli generic drugmaker, resigns amid the company's recent stumbles.

Teva fined $519 million in U.S. for foreign bribes

Israeli generic drug giant Teva will pay $519 million to settle charges that it paid bribes to foreign officials to win business.

Teva to market, distribute medical cannabis inhaler in Israel

Teva Pharmaceutical Industries to become the first major medical company to market and distribute a cannabis inhaler.

Teva completes acquisition of Allergan generics arm

Teva Pharmaceutical completes $40 billion acquisition of the generics arm of rival Allergan.

Teva's $40.5 Billion deal expected to go through next week

Israeli pharmaceutical company wins regulatory approval for acquisition of Allergan, conditional upon giving up some of its products.

Is the next Google being developed in Israel?

Experts disagree as to whether the tech world in Israel is capable of maturing to the level where a tech giant such as Google can exist.

Israeli Pharma Giant Teva Buys Botox's Allergan

$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.

Subsidiary's Crime Costs Israeli Teva $1.2 Billion

Israeli pharma giant to pay for illegal monopoly 'pay for delay' move made by company Cephalon - before Teva acquired it.

Shimon Peres to Advise Teva Pharmaceuticals in Lucrative Deal

Consulting job to the tune of $10,000 per month reportedly on the table; details have not been finalized.

Israeli Pharma Company Teva Looks to Become Global Giant

$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?

Pharmaceutical Giant Teva's Chairman to Resign

Chairman Phillip Frost's announcement the latest in a string of abrupt changes in major Israeli company.

Teva Setback: Competitors Can Sell Copaxone, Court Says

A U.S. Supreme Court Justice gave a green light for competitors of Teva to sell generic versions of multiple sclerosis drug Copaxone.

Erez Vigodman Named New Teva CEO

Teva on Thursday named Erez Vigodman, 54, as new CEO of the company, after last October's controversial resignation of Dr. Jeremy Levin.

Pfizer Settles with Teva on Generic Viagra

Teva will pay Pfizer a royalty for a license to produce its generic version, from late 2017.

Teva Brings 'Captive Profits' Home, Gets Big Tax Break

Teva said Monday that it would return tens billions of shekels to Israel from abroad, and pay a tax bill of nearly three billion shekels.

CEO of Teva Pharmaceuticals Steps Down

Jeremy Levin resigns from the pharmaceutical giant amid tensions in the company

Teva Promises: Layoffs Will be Coordinated with Histadrut

After meeting with Histadrut chairman, pharmaceutical giant promises it will coordinate layoff plans.

Lapid 'Dissatisfied' with Teva Layoffs

Finance Minister says he has spoken to Teva's CEO and asked him to reduce the number of employees the company lays off.

Teva Laying Off 5,000 Employees

Pharmaceutical firm will reduce global manpower by 10%; 700-800 layoffs expected in Israel.

American Jew to Head Teva

American Jew Dr. Jeremy Levin was named new CEO for Teva Pharmaceuticals Monday, when Shlomo Yanai announced he is stepping down.

Former CEO of Teva Pharmaceuticals Dies at 79

Eli Hurvitz, who served as CEO of Teva Pharmaceutical Industries until 2002, passes away from a serious illness.

Israeli Drug: No More Insulin Injections?

Two Israeli-based firms try out a peptide aimed at stopping Type 1 diabetes at its source and eliminate the need for insulin injections.

New Cure for Lymphoma Passes Phase II Clinical Trial

A new treatment for lymphoma, a type of cancer, has passed its Phase II clinical trial. CT-011 is produced by CureTech, a Teva company.

Teva, Appealing Whopping Verdict in US, Opens Giant Center

Israel’s Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, has dedicated its new, $100 million distribution center.

FDA Approves Two Teva Pharmaceuticals Generics, Stocks Gain

Teva Pharmaceuticals enjoys the approval of two new generics by the US Food and Drug Administration, stocks rise.

Teva Acquires German Generic Maker Ratiopharm

Israeli pharmaceutical giant Teva has won the bid to acquire German generic drug maker Ratiopharm for $4.9 billion.

Israel’s TEVA a Headache for Drug Firms, Rx for Investors

Israeli-based TEVA has been called a juggernaut, copy-cat and an 800-pound ape. It makes generic drugs, lots of them, and money – lots of it.

Teva Partners on New Prostate, Lung Cancer Treatment

Israeli pharmaceutical giant Teva has signed a deal to invest $60 million in a new cancer-fighting drug to fight prostate and lung cancer.